Arteriovenous Fistula Tissue Bank
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by University of Nebraska.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
University of Nebraska
Information provided by:
University of Nebraska
ClinicalTrials.gov Identifier:
NCT00836862
First received: February 3, 2009
Last updated: July 15, 2010
Last verified: July 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This project will bank sera, DNA and vascular specimens from patients undergoing arteriovenous fistula creation and revision
| Condition | Intervention |
|---|---|
|
Kidney Failure, Chronic |
Other: Biologic specimens |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Arteriovenous Fistula Tissue Bank |
Resource links provided by NLM:
Genetics Home Reference related topics:
capillary malformation-arteriovenous malformation syndrome
Parkes Weber syndrome
U.S. FDA Resources
Further study details as provided by University of Nebraska:
Biospecimen Retention: Samples With DNA
Serum, Whole Blood, Tissue
| Estimated Enrollment: | 50 |
| Study Start Date: | February 2009 |
| Estimated Primary Completion Date: | November 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Arteriovenous Fistula |
Other: Biologic specimens
Banking of serum, DNA and tissue
|
Eligibility| Ages Eligible for Study: | 19 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Patients will be eligible if they are 19 years of age or greater and have placement of an arteriovenous fistula planned witin 30 days.
Criteria
Inclusion Criteria:
- Age 19 years of age or greater
- Arteriovenous fistula placement for hemodialysis access scheduled within 30 days
Exclusion Criteria:
- Incompetent to provide informed consent
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00836862
Locations
| United States, Nebraska | |
| University of Nebraska Medical Center/The Nebraska Medical Center | Recruiting |
| Omaha, Nebraska, United States, 68105 | |
| Contact: LuAnn Larson, RN, BSN 402-559-8555 llarson@unmc.edu | |
| Principal Investigator: Troy J Plumb, MD | |
Sponsors and Collaborators
University of Nebraska
More Information
No publications provided
| Responsible Party: | Troy J. Plumb, MD, University of Nebraska Medical Center |
| ClinicalTrials.gov Identifier: | NCT00836862 History of Changes |
| Other Study ID Numbers: | 482-08-EP |
| Study First Received: | February 3, 2009 |
| Last Updated: | July 15, 2010 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Nebraska:
|
Hemodialysis Vascular access Arteriovenous fistula |
Additional relevant MeSH terms:
|
Arteriovenous Fistula Fistula Kidney Failure, Chronic Renal Insufficiency Arteriovenous Malformations Vascular Malformations Cardiovascular Abnormalities Cardiovascular Diseases |
Vascular Fistula Vascular Diseases Congenital Abnormalities Pathological Conditions, Anatomical Renal Insufficiency, Chronic Kidney Diseases Urologic Diseases |
ClinicalTrials.gov processed this record on May 19, 2013